A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification

Journal of Applied Clinical Medical Physics

Volumn 14, Issue 6, 2013, Pages 274-292

  Hussein, Mohammad ^a,b   Adams, Elizabeth J ^a   Jordan, Thomas J ^a   Clark, Catharine H ^a,c   Nisbet, Andrew ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c NATIONAL PHYSICAL LABORATORY   (United Kingdom)

Author keywords

Detector arrays; IMRT; QA; VMAT

Indexed keywords

EID: 84888413988     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v14i6.4460     Document Type: Article

References (39)

1. Bortfeld T. IMRT: a review and preview. Phys Med Biol. 2006;51(13):R363-R379.
2. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310-317.
3. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011;84(1007):967-996.
4. Carver A, Gilmore M, Riley S, Uzan J, Mayles P. An analytical approach to acceptance criteria for quality assurance of Intensity Modulated Radiotherapy. Radiother Oncol. 2011;100(3):453-455.
5. Feygelman V, Zhang G, Stevens C, Nelms BE. Evaluation of a new VMAT QA device, or the "X" and "O" array geometries. J Appl Clin Med Phys. 2011;12(2):3346.
6. Masi L, Casamassima F, Doro R, Francescon P. Quality assurance of volumetric modulated arc therapy: evaluation and comparison of different dosimetric systems. Med Phys. 2011;38(2):612-621.
7. Garcia-vicente F, Fernandez V, Bermudez R, et al. Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QA. J Appl Clin Med Phys. 2012;13(1):111-123.
8. Letourneau D, Gulam M, Yan D, Oldham M, Wong JW. Evaluation of a 2D diode array for IMRT quality assurance. Radiother Oncol. 2004;70(2):199-206.
9. Yan G, Liu C, Simon TA, Peng LC, Fox C, Li JG. On the sensitivity of patient-specific IMRT QA to MLC positioning errors. J Appl Clin Med Phys. 2009;10(1):2915.
10. Spezi E, Angelini AL, Romani F, Ferri A. Characterization of a 2D ion chamber array for the verification of radiotherapy treatments. Phys Med Biol. 2005;50(14):3361-3373.
11. Poppe B, Djouguela A, Blechschmidt A, Willborn K, Ruhmann A, Harder D. Spatial resolution of 2D ionization chamber arrays for IMRT dose verification: single-detector size and sampling step width. Phys Med Biol. 2007;52(10):2921-2935.
12. Poppe B, Blechschmidt A, Djouguela A, et al. Two-dimensional ionization chamber arrays for IMRT plan verification. Med Phys. 2006;33(4):1005-1015.
13. Van Esch A, Clermont C, Devillers M, Iori M, Huyskens DP. On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom. Med Phys. 2007;34(10):3825-3837.
14. Syamkumar SA, Padmanabhan S, Sukumar P, Nagarajan V. Characterization of responses of 2d array seven29 detector and its combined use with octavius phantom for the patient-specific quality assurance in rapidarc treatment delivery. Med Dosim. 2012;37(1):53-60.
15. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656-661.
16. Ulmer W, Pyyry J, Kaissl W. A 3D photon superposition/convolution algorithm and its foundation on results of Monte Carlo calculations. Phys Med Biol. 2005;50(8):1767-1790.
17. Spezi E, Angelini AL, Ferri A. A multiple acquisition sequence for IMRT verification with a 2D ion chamber array. Med Dosim. 2006;31(4):269-272.
18. Richley L, John AC, Coomber H, Fletcher S. Evaluation and optimization of the new EBT2 radiochromic film dosimetry system for patient dose verification in radiotherapy. Phys Med Biol. 2010;55(9):2601-2617.
19. Buonamici FB, Compagnucci A, Marrazzo L, Russo S, Bucciolini M. An intercomparison between film dosimetry and diode matrix for IMRT quality assurance. Med Phys. 2007;34(4):1372-1379.
20. ICRU. Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83. Bethesda (MD): ICRU; 2010.
21. Sanchez-nieto B, Nahum AE. BIOPLAN: software for the biological evaluation of radiotherapy treatment plans. Med Dosim. 2000;25(2):71-76.
22. Webb S and Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 1993;38(6):653-666.
23. Sanchez-nieto B and Nahum AE. The delta-TCP concept: a clinically useful measure of tumor control probability. Int J Radiat Oncol Biol Phys. 1999;44(2):369-380.
24. Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol. 1994;39(11):1895-1914.
25. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985;8:S13-S19.
26. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123-135.
27. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 1991;21(1):137-146.
28. Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys. 1999;26:1100.
29. Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S116-S122.
30. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.
31. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45(1):255-168.
32. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S42-S49.
33. Hartmann B, Martišíková M, Jäkel O. Technical Note: Homogeneity of Gafchromic® EBT2 film. Med Phys. 2010;37(4):1727-1730.
34. Chandaraj V, Stathakis S, Manickam R, Esquivel C, Supe SS, Papanikolaou N. Comparison of four commercial devices for RapidArc and sliding window IMRT QA. J Appl Clin Med Phys. 2011;12(2):338-349.
35. Childress NL, Bloch C, White RA, Salehpour M, Rosen II. Detection of IMRT delivery errors using a quantitative 2D dosimetric verification system. Med Phys. 2005;32(1):153-162.
36. Zhen H, Nelms BE, Tome WA. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA. Med Phys. 2011;38(10):5477-5489.
37. Agazaryan N, Solberg TD, Demarco JJ. Patient specific quality assurance for the delivery of intensity modulated radiotherapy. J Appl Clin Med Phys. 2003;4(1):40-50.
38. Hu W, Graff P, Boettger T, Pouliot J. A spatially encoded dose difference maximal intensity projection map for patient dose evaluation: a new first line patient quality assurance tool. Med Phys. 2011;38(4):1748-1753.
39. Li H, Dong L, Zhang L, Yang JN, Gillin MT, Zhu XR. Toward a better understanding of the gamma index: investigation of parameters with a surface-based distance method. Med Phys. 2011;38(12):6730-6741.